News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
Health & Biotech
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
News
ASX July Winners: The best 50 stocks in a strong month for markets
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX tumbles on Fedspeak; gold and oil jump as Middle East tension escalates
News
Market Highlights: Big Tech rebounds sharply, Costco in the gold game, and 5 small caps to watch today
News
ASX Small Caps and IPO Weekly Wrap: A short week for a small win on the ASX
News
Closing Bell: Tech leads ASX selloff; sluggish iron ore, gold prices also weigh on miners
News
Top 10 at 10: Big bagging health stocks and some impressive (unstimulated) gas flow
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A cap raise and renewed gold exploration licence seal the deal today
News
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
Health & Biotech
ASX Health Stocks: Oncosil advances pancreatic cancer device to Greece, its third potential market in Europe
News
Market Highlights: AI stocks up as Google unveils ChatGPT’s rival Gemini, and 5 ASX small caps to watch
News
